Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.

[1]  Tsuyoshi Saito,et al.  Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. , 2018, Human pathology.

[2]  Tsuyoshi Saito,et al.  Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases , 2016, Gastric Cancer.

[3]  T. Gotoda,et al.  Histologic and Immunohistochemical Analyses of &agr;-Fetoprotein—Producing Cancer of the Stomach , 2012, The American journal of surgical pathology.

[4]  S. Shi,et al.  Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach. , 2011, Chinese medical journal.

[5]  W. Sheng,et al.  Analysis of Clinicopathologic Features and Prognostic Factors in Hepatoid Adenocarcinoma of the Stomach , 2010, The American journal of surgical pathology.

[6]  M. Fukayama,et al.  SALL4 Represents Fetal Gut Differentiation of Gastric Cancer, and is Diagnostically Useful in Distinguishing Hepatoid Gastric Carcinoma From Hepatocellular Carcinoma , 2010, The American journal of surgical pathology.

[7]  H. Aburatani,et al.  Glypican 3‐expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear‐cell, and α‐fetoprotein‐producing gastric carcinomas , 2009, Cancer science.

[8]  N. Carr.  Tubulopapillary clear cell carcinoma of the stomach may be a type of pylorocardiac carcinoma. , 2008, Pathology.

[9]  S. Serra,et al.  Clear cell (glycogen rich) gastric adenocarcinoma: a distinct tubulo‐papillary variant with a predilection for the cardia/gastro‐oesophageal region , 2007, Pathology.

[10]  M. Tsuneyoshi,et al.  Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. , 2007, Human pathology.

[11]  B. Clarke,et al.  Clear cell (glycogen-rich) gastric adenocarcinoma. , 2004, Annals of diagnostic pathology.

[12]  J. Shimazaki,et al.  Hepatoid adenocarcinoma of the stomach , 2001, Gastric Cancer.

[13]  T. Kishimoto,et al.  Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis , 2000, Medical Electron Microscopy.

[14]  X. Li,et al.  [Histopathological and immunohistochemical studies in hepatoid adenocarcinomas of the stomach]. , 1996, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[15]  A. Mukawa,et al.  Alpha‐fetoprotein–producing gastric carcinoma with enteroblastic differentiation , 1994, Cancer.

[16]  H. Watanabe,et al.  α‐Fetoprotein producing gastric carcinomas: A comparative study of three different subtypes , 1993, Acta pathologica japonica.

[17]  N. Nagasue,et al.  Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. , 1992, The American journal of gastroenterology.

[18]  F. Rilke,et al.  Gastrointestinal Pathology: An Atlas and Text , 1991, Journal of Pediatric Gastroenterology and Nutrition.

[19]  M. Shamoto,et al.  Hepatoid adenocarcinomas of the stomach: An analysis of seven cases , 1986, Cancer.

[20]  Mulligan Rm,et al.  Histogenesis and biologic behavior of gastric carcinoma: study of one hundred thirty-eight cases. , 1954 .

[21]  R. Mulligan,et al.  Histogenesis and biologic behavior of gastric carcinoma: study of one hundred thirty-eight cases. , 1954, A.M.A. archives of pathology.

[22]  W J Macdonald,et al.  GASTRIC CARCINOMA. , 1912, Canadian Medical Association journal.